• Mashup Score: 0
    Online Event - 6 month(s) ago

    Brain-derived biomarkers of neurodegenerative diseases are important targets for new therapies. In the context of Alzheimer’s disease, scientists are exploring the use of protein biomarkers for early diagnosis, screening, prognosis prediction, and disease monitoring. But these markers are often present at very low concentrations in plasma or serum, much too low for most existing proteomics assays to detect and measure. In this GEN webinar, Henrik Zetterberg, MD, PhD, an expert in Alzheimer’s disease,

    Source: www.workcast.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GENbio
      GENbio

      Join us in ONE HOUR for our webinar sponsored by @AlamarBio Our guests will discuss their efforts to discover and validate biomarkers for #CNS disorders. They will also discuss the NULISA platform’s multiplex and protein marker detection. Register now: https://t.co/BwdDA8v9T0 https://t.co/swh85yfuxB

  • Mashup Score: 1
    Online Event - 6 month(s) ago

    Brain-derived biomarkers of neurodegenerative diseases are important targets for new therapies. In the context of Alzheimer’s disease, scientists are exploring the use of protein biomarkers for early diagnosis, screening, prognosis prediction, and disease monitoring. But these markers are often present at very low concentrations in plasma or serum, much too low for most existing proteomics assays to detect and measure. In this GEN webinar, Henrik Zetterberg, MD, PhD, an expert in Alzheimer’s disease,

    Source: www.workcast.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GENbio
      GENbio

      Join us LATER TODAY for our webinar sponsored by @AlamarBio Our guests will discuss their efforts to discover and validate biomarkers for #CNS disorders. They will also discuss the NULISA platform’s multiplex and protein marker detection. Register now: https://t.co/BwdDA8v9T0 https://t.co/cZZF4hfKi5

  • Mashup Score: 0
    Online Event - 6 month(s) ago

    Brain-derived biomarkers of neurodegenerative diseases are important targets for new therapies. In the context of Alzheimer’s disease, scientists are exploring the use of protein biomarkers for early diagnosis, screening, prognosis prediction, and disease monitoring. But these markers are often present at very low concentrations in plasma or serum, much too low for most existing proteomics assays to detect and measure. In this GEN webinar, Henrik Zetterberg, MD, PhD, an expert in Alzheimer’s disease,

    Source: www.workcast.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GENbio
      GENbio

      Join us TOMORROW for our free webinar sponsored by @AlamarBio Our guests will discuss their efforts to discover and validate biomarkers for #CNS disorders. They will also discuss the NULISA platform’s multiplex and protein marker detection. Register now: https://t.co/BwdDA8v9T0 https://t.co/0dRD10c0aZ

  • Mashup Score: 3
    Online Education - cns.org - 6 month(s) ago

    Endoscopic Webinars Elevate your understanding of endoscopic procedures and stay on the cutting-edge of science with our other webinars in the series today! The CNS has recently added two new webinars to our growing library of endoscopic content: Intracranial Endoscopy Beyond the Skull Base: Hydrocephalus and Oncology and Spine.  Pricing Rates:  Member: $75.00 Nonmember: $125.00  Residents: free…

    Source: www.cns.org
    Categories: Latest Headlines, Neurology
    Tweet Tweets with this article
    • Profile photo of CNS_Update
      CNS_Update

      Earn 16 CME from the CNS Trauma Bundle featuring 6 different activities like SANS: Trauma & Neurocritical Care Module, Moderate-severe TBI Guidelines & Protocols Review, and more! Get your bundle today: https://t.co/FfYqA5lyXN #cns #neurosurgery #trauma https://t.co/fYIZ0p9MHR

  • Mashup Score: 0
    Nidus - cns.org - 11 month(s) ago

    Access neurosurgical experts for decision support—on demand with the CNS and Nidus! The CNS is collaborating with Nidus to help our members and their patients make better-informed decisions together.   “Nidus is an outstanding forum where the experts in brain tumor surgery can provide an opinion on a brain tumor case, leading to a consensus about best in class treatment strategies!”- E. Antonio…

    Source: www.cns.org
    Categories: Latest Headlines, Neurology
    Tweet Tweets with this article
    • Profile photo of CNS_Update
      CNS_Update

      CNS' collaboration with #Nidus enables you to obtain a virtual consult with an international panel of experts—all within 72 hours. Benefit from the confidence that comes with this decision-support tool in choosing the best management. https://t.co/znO5azgcq0 #cns #nsgy #experts https://t.co/WTEE4z9O76

  • Mashup Score: 0
    Caltech’s Enzyme Discovery Enables New Mechanism for Crossing the Blood–Brain Barrier - 12 month(s) ago

    Caltech researchers discovered an enzyme that enables viral vectors to cross the blood-brain barrier, potentially aiding brain disorder drug development and research. The blood–brain barrier (BBB) is a stringent, nearly impenetrable layer of cells that guards the brain, protecting the vital organ

    Source: SciTechDaily
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of westr
      westr

      Caltech’s Enzyme Discovery Enables New Mechanism for Crossing the Blood–#BrainBarrier - https://t.co/ce2GGgeab4 #CNS #BBB #CAIV #CarbonicAnhydrase Primate-conserved carbonic anhydrase IV and murine-restricted #LY6C1 enable #bloodbrainbarrier crossing by engineered #viralvectors… https://t.co/V7BXP6awxu https://t.co/64xHqvXt9U

Load More